发明授权
- 专利标题： Macrocyclic hepatitis C serine protease inhibitors
- 专利标题（中）： 大环丙肝丝氨酸蛋白酶抑制剂
-
申请号： EP14181565.4申请日： 2009-09-10
-
公开(公告)号： EP2805726B1公开(公告)日： 2018-05-02
- 发明人: Ku, Yiyin , Or, Yat, Sun , Wagaw, Sable, H. , Engstrom, Ken , Grieme, Tim , Sheikh, Ahmad , Mei, Jianzhang , McDaniel, Keith, F. , Chen, Hui-ju , Shanley, Jason, P. , Kempf, Dale, J. , Grampovnik, David, J. , Gai, Yonghua , Sun, Ying , Liu, Dong
- 申请人： Enanta Pharmaceuticals, Inc. , AbbVie Ireland Unlimited Company
- 申请人地址： 500 Arsenal Street Watertown, MA 02472 US
- 专利权人： Enanta Pharmaceuticals, Inc.,AbbVie Ireland Unlimited Company
- 当前专利权人： Enanta Pharmaceuticals, Inc.,AbbVie Ireland Unlimited Company
- 当前专利权人地址： 500 Arsenal Street Watertown, MA 02472 US
- 代理机构： Modiano, Micaela Nadia
- 优先权： US191725P 20080911; US209689P 20090310
- 主分类号： A61K38/00
- IPC分类号： A61K38/00 ; A61K38/12 ; C07D487/04
摘要：
The present invention relates to novel macrocyclic compounds and methods of use thereof. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.
公开/授权文献
- EP2805726A1 Macrocyclic hepatitis C serine protease inhibitors 公开/授权日：2014-11-26
信息查询
IPC分类:
